company

MEDICALL ANALYSE NORGE

0164 OSLO

Return on Equity
−17,46 %
Current Ratio
0,95
Debt-to-Equity Ratio
−0
Key figures (NOK)2022
Revenue881 000
Net Income11 000
Total Assets1 160 000
Total Equity−63 000
Income (NOK)2022
Revenue881 000
Expenditure870 000
Operating Profit11 000
Financial Income0
Financial Costs0
Financial Balance0
Earnings Before Tax11 000
Tax0
Net Income11 000
Balance (NOK)2022
Total Fixed Assets0
Total Current Assets1 160 000
Total Assets1 160 000
Total Retained Equity−63 000
Total Equity−63 000
Total Long-Term Debt0
Total Current Debt1 223 000
Total Equity and Debt1 160 000
Cash flow (NOK)2022
Sales Income881 000
Other Income0
Revenue881 000
Cost of Goods Sold837 000
Salary Costs0
Depreciation0
Impairment0
Expenditure870 000
Operating Profit11 000
Financial Income0
Financial Costs0
Financial Balance0
Dividends0
Net Income11 000
Balance details (NOK)2022
Goodwill0
Total Intangible Assets0
Real Eastate0
Machinery and Plant Facilities0
Fixtures0
Total Tangible Assets0
Total Fiancial Fixed Assets0
Total Fixed Assets0
Stock0
Total Investments0
Cash, Bank628 000
Total Current Assets1 160 000
Total Assets1 160 000
Total Equity−63 000
Short-Term Group Debt0
Total Long-Term Debt0
Creditors377 000
Unpaid Taxes69 000
Dividends0
Other Current Debt776 000
Total Current Debt1 223 000
Total Equity and Debt1 160 000
Financial indicators2022
Return on Equity−17,46 %
Debt-to-Equity Ratio−0
Operating Profit Margin1,25 %
Current Ratio0,95
Quick Ratio0,95
Equity Ratio−0,05
Gross Profit Margin4,99 %
RotateRotate your device to see the full table
HomeIndustriesNew CompaniesAbout
🇳🇴Norsk🇬🇧English